Development of [ 18F]FRP-170 injection for imaging hypoxia by PET

Yoichi Ishikawa, Yoshihito Funaki, Ren Iwata, Shozo Furumoto, Eiko Nakata, Yukitsuka Kudo, Tomohiro Kaneta, Takashi Hakamatsuka, Yoshihiro Takai, Shogo Yamada

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


A novel [ 18F]FRP-170 injection for imaging hypoxia by PET was developed for clinical use. The preparation was based on the simple on-column basic-hydrolysis and the whole procedure was automated by detecting He flow change for transferring and evaporating liquids. [ 18F]FRP-170 was prepared in around 15-20% decay-corrected radiochemical yield within 60 min and stable in saline for more than 6 hr. Radiochemical purity was over 99% and specific activity at EOS was 40-60 GBq/μmol. The radiation-absorbed dose to the whole body was estimated to be 1.0 mSv/185 MBq. The [ 18F]FRP-170 injection proved to be suitable for clinical use without acute toxicity or mutagenicity.

Original languageEnglish
Pages (from-to)1-10
Number of pages10
JournalKaku igaku. The Japanese journal of nuclear medicine
Issue number1
Publication statusPublished - 2005


  • Automated synthesis
  • F-18
  • FRP-170
  • Hypoxic cell maker
  • PET radiopharmaceutical


Dive into the research topics of 'Development of [ 18F]FRP-170 injection for imaging hypoxia by PET'. Together they form a unique fingerprint.

Cite this